Edwards Lifesciences C - COM Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q2 2024

Type / Class
Equity / COM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Edwards Lifesciences C - COM across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$1,827,000 0
2024 Q1 19,122 $1,827,000 -$135,673 $95.54 1
2023 Q4 20,542 $1,566,000 +$1,566,000 $76.23 1
2023 Q3 0 $0 -$2,061,000 0
2023 Q2 21,847 $2,061,000 +$2,061,000 $94.34 1
2022 Q4 0 $0 -$5,000 0
2022 Q3 60 $5,000 +$5,000 $83.33 1
2022 Q2 0 $0 -$7,000 0
2022 Q1 60 $7,000 $116.67 1
2021 Q4 60 $8,000 $133.33 1
2021 Q3 60 $7,000 +$7,000 $116.67 1
2020 Q4 0 $0 -$9,000 0
2020 Q3 110 $9,000 -$3,273 $81.82 1
2020 Q2 150 $10,000 -$1,629,000 $66.67 1
2020 Q1 8,690 $1,639,000 -$4,456 $188.61 1
2019 Q4 8,700 $2,030,000 -$44,259 $236.65 2
2019 Q3 8,890 $1,955,000 +$9,000 $222.44 2
2019 Q2 8,850 $1,635,000 -$9,237 $184.75 1
2019 Q1 8,900 $1,703,000 $191.35 1
2018 Q4 8,900 $1,363,000 $153.15 1
2018 Q3 8,900 $1,549,000 +$1,549,000 $174.04 1
2018 Q2 0 $0 -$1,090,000 0
2018 Q1 7,810 $1,090,000 +$6,978 $139.56 1
2017 Q4 7,760 $875,000 +$875,000 $112.76 1